Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.43 +0.08 (+0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Cost of Revenue (2013 - 2026)

Updated

Amphastar Pharmaceuticals' Cost of Revenue came in at $90.43 million for Q2 2026, up 2.9% from $87.92 million a year earlier but down 10.3% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Cost of Revenue (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amphastar Pharmaceuticals reported Cost of Revenue of $381.91 million, up 5.4% year-over-year; for FY2025, it was $363.83 million, up 1.6% from FY2024.

  • Cost of Revenue has increased in each of the last eight years, with a five-year compound annual growth rate of 12.0% (FY2020 to FY2025).
  • Going back by year, Cost of Revenue was $358.11 million in FY2024 (+22.1%), $293.27 million in FY2023 (+17.3%), $250.13 million in FY2022 (+5.1%) and $238.03 million in FY2021 (+15.3%).
  • The five-year range for quarterly Cost of Revenue is $60.11 million (Q2 2022) to $100.85 million (Q1 2026).
  • Year-over-year, Cost of Revenue increased in seven of the last eight quarters, with growth averaging 9.2%.
  • The fastest year-over-year change in Cost of Revenue over five years came in Q3 2021 (growth of 30.0%), and the weakest in Q4 2025 (a decline of 2.4%).
  • Business Quant data shows AMPH's Cost of Revenue at $100.85 million (Q1 2026), $97.44 million (Q4 2025) and $93.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Amphastar Pharmaceuticals 1.08 Bn -59.50 Mn 93.47 Mn 90.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.43 Mn
Mar 31, 2026 100.85 Mn
Dec 31, 2025 97.44 Mn
Sep 30, 2025 93.19 Mn
Jun 30, 2025 87.92 Mn
Mar 31, 2025 85.28 Mn
Dec 31, 2024 99.88 Mn
Sep 30, 2024 89.27 Mn
Jun 30, 2024 87.23 Mn
Mar 31, 2024 81.74 Mn
Dec 31, 2023 81.97 Mn
Sep 30, 2023 72.15 Mn
Jun 30, 2023 72.97 Mn
Mar 31, 2023 66.18 Mn
Dec 31, 2022 63.86 Mn
Sep 30, 2022 61.62 Mn
Jun 30, 2022 60.11 Mn
Mar 31, 2022 64.54 Mn
Dec 31, 2021 64.65 Mn
Sep 30, 2021 61.02 Mn
API Access

Amphastar Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AMPH&period=max&api_key=YOUR_API_KEY